South Florida biotech raises $56M in Series A funding
Another South Florida health care startup has raised a significant round of funding as venture capital investments rebound in the region.
X-Vax Technology, a biotechnology firm based in Jupiter, has raised $56 million in upsized Series A financing with impressive backers. Adjuvant Capital, a fund supported by the& Melinda Gates Foundation, made its first investment in advancing the South Florida company's herpes vaccination research alongside co-investors including Johnson& Johnson Innovation, …
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Emon Reiser Source Type: news
More News: Biotechnology | Funding | Health Management | Herpes | Pharmaceuticals | Vaccines | Venture Capital